September 26, 2012 (Ottawa, Ontario) — Primary-care practitioners may be putting the lives of patients with prosthetic heart valves at risk by switching their anticoagulation from warfarin to newer ...
Patients undergoing surgical aortic or mitral valve replacement with bioprostheses in the United States are increasingly being prescribed direct oral anticoagulants (DOACs) at discharge, despite the ...
Heart transcatheter The FDA has approved the supplemental New Drug Application for Xarelto (rivaroxaban; Janssen) to include updated information for patients with prosthetic heart valves. The Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results